ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,217.33
-0.37%
Dow Jones
39,112.16
0.00%
Gold vs US Dollar
2,314.225
-0.28%
Brent Oil
84.32
0.16%
Bitcoin
61,513.54
-0.47%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Organogenesis Holdings Inc (ORGO) Share Price

ORGO Organogenesis Holdings Inc

2.50
0.00 (0.00%)
Pre Market
Last Updated: 12:07:01
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Organogenesis Holdings Inc NASDAQ:ORGO NASDAQ Common Stock  Class A Common Stock
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00 0.00 2.50 2.34 2.60 0.00 0.00   11:07:01   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Coml Physical, Biologcl Resh 433.14M 4.95M 0.0373 67.02 331.43M
 Type  Size  Price  Time  Units 
   0.00  
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ORGO News
06/06/202421:05GLOBEOrganogenesis Holdings Inc. to Participate in the Truist Securities MedTech Conference
09/05/202421:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/05/202421:05GLOBEOrganogenesis Holdings Inc. Reports First Quarter 2024 Financial Results
02/05/202412:00GLOBEOrganogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis
16/04/202412:30GLOBEOrganogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
03/04/202412:30GLOBEOrganogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case
29/02/202421:31EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Period
Draw mode
Data Downloads for ORGO

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Organogenesis Holdings Inc Articles